cmAngio
cmAngio is intended to process screening mammograms to aid a qualified interpreting physician in the current manual process of identifying Breast Arterial Calcification (BAC).
cmAngio, a proprietary artificial intelligence (AI) based software, is intended to detect, at the study and breast level, the presence or absence of Breast Arterial Calcifications (BAC), an incidental finding in both Full Field Digital Mammogram (FFDM) and Digital Breast Tomosynthesis (DBT) screening mammograms. The device also marks BAC segments on thumbnails of images for localization of BAC.
The software is intended to be used by qualified interpreting physicians in parallel with breast screening mammography workflow. The device is not intended for primary interpretation of digital mammography images as used for breast cancer detection and should not be used alone to make any diagnosis and/or treatment decisions.
FDA 510(k): K232367
HC_4404_June2024
MEDICAL DEVICE DISCLAIMER. Microsoft and Nuance Products are not designed, intended, or made available as a medical device(s), and are not designed or intended to be a substitute for professional medical advice, diagnosis, treatment, or judgment and should not be used to replace or as a substitute for professional medical advice, diagnosis, treatment, or judgment.
The Nuance Precision Imaging Network (PIN) provides access to—but does not generate, modify, review, or approve—findings or insights produced by independent Third-Party AI applications. Nuance makes no representation or warranty related to the regulatory status or sufficiency of any Third-Party AI application.